CIK 0001070081 · Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043416587
- Phone
- 9082227000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,752,145
- in 10 filings, $7.8M under 10b5-1 plans
Net −$7,752,145. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-06 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −601 | $86.38 | $52K | 105,272 |
| 2026-07-06 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +2,813 | $46.54 | $131K | 108,085 |
| 2026-07-06 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −387 | $83.10 | $32K | 107,698 |
| 2026-07-06 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −1,036 | $84.41 | $87K | 106,662 |
| 2026-07-06 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −645 | $85.84 | $55K | 106,017 |
| 2026-07-06 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −745 | $86.38 | $64K | 105,272 |
| 2026-07-06 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,226 | 4,532 | ||
| 2026-07-06 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,813 | 28,125 | ||
| 2026-07-06 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise 10b5-1 | +811 | $38.10 | $31K | 61,110 |
| 2026-07-06 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −426 | $85.28 | $36K | 60,684 |
| 2026-07-06 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −385 | $86.34 | $33K | 60,299 |
| 2026-07-06 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise 10b5-1 | +18,876 | $38.10 | $719K | 79,175 |
| 2026-07-06 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −8,786 | $85.35 | $750K | 70,389 |
| 2026-07-06 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −10,090 | $86.32 | $871K | 60,299 |
| 2026-07-06 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise 10b5-1 | +2,474 | $39.42 | $98K | 62,773 |
| 2026-07-06 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −2,474 | $87.03 | $215K | 60,299 |
| 2026-07-06 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −811 | 18,876 | ||
| 2026-07-06 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,876 | 0 | ||
| 2026-07-06 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,474 | 33,676 | ||
| 2026-06-26 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise 10b5-1 | +412 | $38.10 | $16K | 60,549 |
Page 4 of 25 · 493 trades